Skip to content

Apotheek Colpaert

Active Private limited companyfounded 2012active for 14 yearsHippodroomstraat 3, 8530 HarelbekeKBO/BCE: BE 0845.626.204

Lifetime

13 annual accounts with figures on one time axis
peak of €74,272 in 2013
€44,846▼ 20.8%
peak of €31,432 in 2024
€24,608▼ 21.7%
peak of €297,719 in 2025
€297,719▲ 4.4%
€53,816▼ 19.0%
Board2 names since 2012
2 directors and 1 other
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €56,601 to €44,846Dividend €12,030Debts from €66,478 to €53,816

Key points

from the 2025 annual accounts

Equity

€297,719 ▲ 4.4%

Apotheek Colpaert has made a profit in every financial year since 2013.

Filings

13 annual accounts since 2013
AprilJune31 JulyOctober201520202025

The 2018 accounts came 28 days late. The other nine of the last ten were filed on time.

Position in the sector

84.7%

Higher solvency than 90% of companies in retail trade. The sector median is 33.3%, over 25,414 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as Apotheek Colpaert has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for Apotheek Colpaert. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 150 sharesdeed of 11-05-2012
  • 150 sharesdeed of 11-05-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0845626204
appointed as director “Het administratief en commercieel beheer van één of meer apotheken uitgebaat onder het wetenschappelijk…” (deed in Dutch) · General meeting of 22-06-2023 · Gazette deed
Publication in the Belgian Official Gazette Gazette deed
First establishment Hippodroomstraat 3, Harelbeke
All 23 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Colpaert Harelbeke €351,535 €44,846 84.7% -
MEDISERVICES Esneux €358,197 €45,303 -30.6% -
DEWEZ INVEST Visé €419,029 €46,707 21.5% -
APOTHEEK ROSSEEL Huldenberg €370,275 €37,444 30.9% -
FARMA FLOROSA Heist-op-den-Berg €350,389 €58,345 95.1% -
FARMALIA Etterbeek €397,775 €43,692 -3.8% -
Apotheek Loosveldt Anzegem €264,627 €38,519 72.7% -

These companies have the same main activity as Apotheek Colpaert: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €265,000 and €419,000, founded between 2009 and 2015.

Official details

Source: KBO
Status
Active since 26-04-2012Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.209.361.3778530 Harelbeke, since 20-05-2012
Financial year end
31 December
Peppol
Reachable since 25-07-2025
Company details

Annual accounts 2025

≈ €200,000estimated
€351,535=
Filing
Filed on 23-06-2026, 38 days before the end of the filing period
Financials

Insights on Apotheek Colpaert

Apotheek Colpaert files the micro format. That format states no turnover. The gross margin fell from €74,272 in 2013 to €44,846 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Colpaert

What is the company number of Apotheek Colpaert?
The company number of Apotheek Colpaert is 0845.626.204. The VAT number is the same number with BE in front: BE 0845.626.204.
Where is Apotheek Colpaert based?
The registered office is at Hippodroomstraat 3, 8530 Harelbeke.Company details
What does Apotheek Colpaert do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Colpaert?
Apotheek Colpaert is a private limited company (BV).
When was Apotheek Colpaert founded?
Apotheek Colpaert was founded on 26-04-2012.
Is Apotheek Colpaert still active?
Yes, Apotheek Colpaert is an active enterprise in the KBO register.
What is the turnover of Apotheek Colpaert?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €44,846 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €370,000.Financials
Is Apotheek Colpaert profitable?
In financial year 2025, Apotheek Colpaert made a profit of €24,608.
Where can I find the annual accounts of Apotheek Colpaert?
Apotheek Colpaert filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Colpaert due?
Apotheek Colpaert must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.